Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/55166
Type
ArticleCopyright
Open access
Collections
- ENSP - Artigos de Periódicos [2411]
- INCQS - Artigos de Periódicos [393]
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record
COST-EFFECTIVENESS OF AN EXERCISE-BASED CARDIOVASCULAR REHABILITATION PROGRAM IN PATIENTS WITH CHRONIC CHAGAS CARDIOMYOPATHY IN BRAZIL: AN ANALYSIS FROM THE PEACH STUDY
Cardiac rehabilitation program
Chronic Chagas cardiomyopathy
Cost-effectiveness analysis
Author
Simões, Valeria Alencar Linhares
Mendes, Fernanda de Souza Nogueira Sardinha
Avellar, Alexandre Monken
Silva, Gilberto Marcelo Sperandio da
Carneiro, Fernanda Martins
Silva, Paula Simplicio da
Mazzoli-Rocha, Flavia
Silva, Rudson Santos
Vieira, Marcelo Carvalho
Costa, Celson Junio do Nascimento
Sousa, Andrea Silvestre de
Rosalino, Claudia Maria Valete
Nobre, Patricia Fernandes da Silva
Holanda, Marcelo Teixeira de
Costa, Henrique Silveira
Saraiva, Roberto Magalhaes
Hasslocher-Moreno, Alejandro Marcel
Castro, Rodolfo
Mediano, Mauro Felippe Felix
Mendes, Fernanda de Souza Nogueira Sardinha
Avellar, Alexandre Monken
Silva, Gilberto Marcelo Sperandio da
Carneiro, Fernanda Martins
Silva, Paula Simplicio da
Mazzoli-Rocha, Flavia
Silva, Rudson Santos
Vieira, Marcelo Carvalho
Costa, Celson Junio do Nascimento
Sousa, Andrea Silvestre de
Rosalino, Claudia Maria Valete
Nobre, Patricia Fernandes da Silva
Holanda, Marcelo Teixeira de
Costa, Henrique Silveira
Saraiva, Roberto Magalhaes
Hasslocher-Moreno, Alejandro Marcel
Castro, Rodolfo
Mediano, Mauro Felippe Felix
Affilliation
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Aloysio de Castro State Institute of Cardiology. Centre for Cardiology and Exercise. Rio de Janeiro, RJ, Brazil.
National Institute of Cardiology. Department of Research and Education. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Controle de Qualidade em Saúde. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Federal University of Vales do Jequitinhonha e Mucuri. Faculty of Healthy and Biological Sciences. Department of Physical Therapy. Diamantina, MG, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil / Federal University of the State of Rio de Janeiro. Institute of Collective Health. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / National Institute of Cardiology. Department of Research and Education. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Aloysio de Castro State Institute of Cardiology. Centre for Cardiology and Exercise. Rio de Janeiro, RJ, Brazil.
National Institute of Cardiology. Department of Research and Education. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Controle de Qualidade em Saúde. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Federal University of Vales do Jequitinhonha e Mucuri. Faculty of Healthy and Biological Sciences. Department of Physical Therapy. Diamantina, MG, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil / Federal University of the State of Rio de Janeiro. Institute of Collective Health. Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / National Institute of Cardiology. Department of Research and Education. Rio de Janeiro, RJ, Brazil.
Abstract
Objectives: The present study aimed to perform a cost-effectiveness analysis of an exercise-based cardiovascular rehabilitation (CR) program in patients with chronic Chagas cardiomyopathy (CCC). Methods: Cost-effectiveness analysis alongside a randomised clinical trial evaluating the effects of a 6-month exercise-based CR program. The intervention group underwent 3 weekly exercise sessions. The variation of peak oxygen consumption (VO2peak ) was used as a measurement of clinical outcome. Cost information from all healthcare expenses (examinations, healthcare visits, medication and hospitalisation) were obtained from the medical records in Brazilian reais (R$) and transformed into dollars using the purchasing power parity ($PPP). The longitudinal costs variation was evaluated through linear mixed models, represented by β coefficient, adjusted for the baseline values of the dependent variable. The cost-effectiveness evaluation was determined through an incremental cost-effectiveness ratio using the HEABS package (Stata 15.0). Results: The intervention group presented higher costs with healthcare visits (β = +3317.3; p < 0.001), hospitalisation (β = +2810.4; p = 0.02) and total cost (β = +6407.9; p < 0.001) after 3 months of follow-up. Costs related to healthcare visits (β = +2455.8; p < 0.001) and total cost (β = +4711.4; p < 0.001) remained higher in the intervention group after 6 months. The CR program showed an incremental cost-effectiveness ratio (ICER) of $PPP 1874.3 for each increase of 1.0 ml kg-1 min-1 of VO2peak. Conclusions: The CR program can be considered a cost-effective alternative and should be included as an intervention strategy in the care of patients with CCC.
Keywords
Chagas diseaseCardiac rehabilitation program
Chronic Chagas cardiomyopathy
Cost-effectiveness analysis
Share